Can freezing bone tumors stop cancer in its tracks?

NCT ID NCT06480955

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 50 people with cancer that has spread to the bones (bone metastases) to see if freezing those tumors with a special probe (cryoablation) can control them. The goal is to prevent local tumor growth, ease pain, and improve quality of life. Participants have limited spread (oligometastatic disease) and are being treated with a curative intent, but the study is observational, meaning it only watches outcomes without comparing to another treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cryoablation (freezing tumor cells using a device from Boston Scientific)
What this could lead to
If successful, this could show that freezing bone metastases helps control local tumor growth and reduces pain, offering a treatment option for people with limited spread of cancer.
What could go wrong
This is an early observational study with only 50 participants, so results may not apply to everyone. Cryoablation carries risks like bleeding, infection, or nerve damage, and it may not prevent new metastases elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU de Strasbourg

    RECRUITING

    Strasbourg, 67200, France

  • CHUV-Lausanne University Hospital

    RECRUITING

    Lausanne, 1011, Switzerland

  • Hospital Universitario y Politécnico La Fe

    RECRUITING

    Valencia, 46026, Spain

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, 94805, France

  • Institute Bergonié

    RECRUITING

    Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.